glp 1 gip 1 Dr.Syed GLP-1 + GIP Injections -

There have been reports of these drugs inducing pancreatitis and recent suggestions that they may predispose to pancreatic cancer

Additionally, it was demonstrated that the long-acting triagonist protected against Parkinson disease in mice by attenuating microglial activation and inflammation in the specific brain regions [31]

Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]

Bjrnsson ES, Abrahamsson H

But what about microdosing taking very small doses long-term